OCUL – Ocular Therapeutix, Inc.
OCUL — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
13.44
Margin Of Safety %
Put/Call OI Ratio
0.24
EPS Next Q Diff
-0.01
EPS Last/This Y
0.08
EPS This/Next Y
-0.13
Price
9.19
Target Price
27.17
Analyst Recom
1.08
Performance Q
-5.06
Upside
-299.5%
Beta
0.94
Ticker: OCUL
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-13 | OCUL | 9.9 | 0.19 | 1.23 | 50240 |
| 2026-07-14 | OCUL | 9.7 | 0.20 | 0.07 | 51603 |
| 2026-07-15 | OCUL | 9.95 | 0.20 | 0.02 | 51847 |
| 2026-07-16 | OCUL | 9.15 | 0.19 | 0.96 | 52769 |
| 2026-07-17 | OCUL | 8.97 | 0.23 | 0.07 | 55065 |
| 2026-07-20 | OCUL | 8.71 | 0.26 | 0.07 | 40073 |
| 2026-07-21 | OCUL | 8.93 | 0.25 | 0.07 | 41214 |
| 2026-07-22 | OCUL | 8.59 | 0.25 | 0.25 | 41326 |
| 2026-07-23 | OCUL | 8.61 | 0.25 | 0.12 | 41865 |
| 2026-07-24 | OCUL | 8.49 | 0.25 | 0.68 | 42227 |
| 2026-07-27 | OCUL | 8.64 | 0.23 | 0.30 | 39773 |
| 2026-07-28 | OCUL | 8.44 | 0.23 | 0.34 | 40558 |
| 2026-07-29 | OCUL | 8.35 | 0.23 | 0.04 | 40832 |
| 2026-07-30 | OCUL | 8.48 | 0.23 | 0.53 | 41104 |
| 2026-07-31 | OCUL | 8.15 | 0.23 | 0.18 | 41506 |
| 2026-08-03 | OCUL | 8.39 | 0.21 | 0.29 | 40024 |
| 2026-08-04 | OCUL | 8.6 | 0.22 | 0.21 | 40651 |
| 2026-08-05 | OCUL | 8.5 | 0.22 | 1.76 | 41536 |
| 2026-08-06 | OCUL | 8.74 | 0.23 | 3.05 | 42025 |
| 2026-08-07 | OCUL | 9.19 | 0.24 | 0.69 | 42429 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-13 | OCUL | 9.89 | 0.8 | - | -1.55 |
| 2026-07-14 | OCUL | 9.70 | 0.8 | - | -1.55 |
| 2026-07-15 | OCUL | 9.95 | 0.8 | - | -1.55 |
| 2026-07-16 | OCUL | 9.16 | 0.8 | - | -1.55 |
| 2026-07-17 | OCUL | 8.97 | 0.8 | - | -1.55 |
| 2026-07-20 | OCUL | 8.71 | 0.8 | - | -1.55 |
| 2026-07-21 | OCUL | 8.93 | 0.8 | - | -1.55 |
| 2026-07-22 | OCUL | 8.59 | 0.8 | - | -1.55 |
| 2026-07-23 | OCUL | 8.61 | 0.8 | - | -1.55 |
| 2026-07-24 | OCUL | 8.51 | 0.8 | - | -1.55 |
| 2026-07-27 | OCUL | 8.64 | 0.8 | - | -1.55 |
| 2026-07-28 | OCUL | 8.44 | 0.8 | - | -1.55 |
| 2026-07-29 | OCUL | 8.35 | 0.8 | - | -1.55 |
| 2026-07-30 | OCUL | 8.47 | 0.8 | - | -1.55 |
| 2026-07-31 | OCUL | 8.16 | 0.8 | - | -1.55 |
| 2026-08-03 | OCUL | 8.40 | 0.8 | - | -1.55 |
| 2026-08-04 | OCUL | 8.40 | 0.8 | - | -1.55 |
| 2026-08-05 | OCUL | 8.50 | -2.0 | - | -1.55 |
| 2026-08-06 | OCUL | 8.75 | -2.0 | - | -1.55 |
| 2026-08-07 | OCUL | 9.19 | 9.7 | - | -1.34 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-13 | OCUL | -0.97 | 0.63 | 13.31 |
| 2026-07-14 | OCUL | -0.97 | 0.63 | 13.31 |
| 2026-07-15 | OCUL | -0.97 | 0.63 | 13.31 |
| 2026-07-16 | OCUL | -0.97 | 0.63 | 13.31 |
| 2026-07-17 | OCUL | -0.97 | 0.63 | 13.31 |
| 2026-07-20 | OCUL | -0.97 | 0.69 | 13.31 |
| 2026-07-21 | OCUL | -0.97 | 0.69 | 13.31 |
| 2026-07-22 | OCUL | -0.97 | 0.69 | 13.31 |
| 2026-07-23 | OCUL | -0.97 | 0.69 | 13.31 |
| 2026-07-24 | OCUL | -0.97 | 0.69 | 13.31 |
| 2026-07-27 | OCUL | -0.97 | 0.73 | 13.48 |
| 2026-07-28 | OCUL | -0.97 | 0.73 | 13.48 |
| 2026-07-29 | OCUL | -0.97 | 0.73 | 13.48 |
| 2026-07-30 | OCUL | -0.97 | 0.73 | 13.48 |
| 2026-07-31 | OCUL | -0.97 | 0.73 | 13.48 |
| 2026-08-03 | OCUL | -0.97 | -0.31 | 13.48 |
| 2026-08-04 | OCUL | -0.97 | -0.31 | 13.48 |
| 2026-08-05 | OCUL | -0.91 | -0.31 | 13.48 |
| 2026-08-06 | OCUL | -0.91 | -0.31 | 13.48 |
| 2026-08-07 | OCUL | -0.91 | -0.31 | 13.44 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.35
Avg. EPS Est. Current Quarter
-0.34
Avg. EPS Est. Next Quarter
-0.36
Insider Transactions
-0.91
Institutional Transactions
-0.31
Beta
0.94
Average Sales Estimate Current Quarter
14
Average Sales Estimate Next Quarter
14
Fair Value
Quality Score
43
Growth Score
34
Sentiment Score
34
Actual DrawDown %
44.1
Max Drawdown 5-Year %
-82.8
Target Price
27.17
P/E
Forward P/E
PEG
P/S
38.78
P/B
3.88
P/Free Cash Flow
EPS
-1.41
Average EPS Est. Cur. Y
-1.34
EPS Next Y. (Est.)
-1.48
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-579.1
Relative Volume
0.77
Return on Equity vs Sector %
-85.3
Return on Equity vs Industry %
-69.2
EPS 1 7Days Diff
0.2
EPS 1 30Days Diff
0.21
EBIT Estimation
◆
OCUL
Healthcare
$9.19
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
54.5
Range 1M
35%
Sup Dist
7.5%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-5.3%
EPS NY
0.5%
52W%
28.4%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+195.6% upside
Upside
+195.6%
Quality
43
OCUL — P/E HistoricalBiotechnology
Ocular Therapeutix, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 325
Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing AXPAXLI, an axitinib intravitreal hydrogel that is in phase 3 clinical trials for the treatment of wet age-related macular degeneration and non-proliferative diabetic retinopathy; OTX-TIC, a travoprost intracameral hydrogel, which has completed phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension. The company has a license agreement and collaboration with AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.
OCUL
Latest News
—
Caricamento notizie per OCUL…
stock quote shares OCUL – Ocular Therapeutix, Inc. Stock Price stock today
news today OCUL – Ocular Therapeutix, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch OCUL – Ocular Therapeutix, Inc. yahoo finance google finance
stock history OCUL – Ocular Therapeutix, Inc. invest stock market
stock prices OCUL premarket after hours
ticker OCUL fair value insiders trading